Iranian Journal of Basic Medical Sciences, 2018 · DOI: 10.22038/IJBMS.2018.24239.6052 · Published: June 1, 2018
Traumatic spinal cord injury (TSCI) has a devastating effect on the patient’s quality of life, family, and society. Current clinical therapies attempt to prevent progression of secondary injuries that initiate after acute mechanical insult. New therapeutic approaches, such as cell therapies, gene therapies, and tissue engineering have been proposed to compensate neuronal loss and inhibitory environment of the injured tissue. Detailed understanding of the time-dependent pathophysiological events after TSCI in animal studies may help scientists to accurately decide the time and type of intervention.
The first 2 weeks post-injury represent a critical time window for therapies aimed at reducing apoptotic neuronal death.
Cell transplantation and neurotrophic factor delivery to the brain stem/brain after TSCI may be a promising intervention.
Selection of the injury model and time of intervention has a crucial role in the efficacy of therapy to preserve spared neurons.